{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:25:53Z","timestamp":1781951153892,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neurol.2021.09.009","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T17:27:09Z","timestamp":1641490029000},"page":"393-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute Varicella-Zoster Virus meningitis in a multiple sclerosis patient treated with fingolimod"],"prefix":"10.1016","volume":"178","author":[{"given":"D.","family":"Dimitri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2021.09.009_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.09.009_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","article-title":"Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management","volume":"72","author":"Arvin","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2021.09.009_bib0050","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3182735d00","article-title":"Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod","volume":"79","author":"Ratchford","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2021.09.009_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/WNL.0000000000001109","article-title":"VZV encephalitis that developed in an immunized patient during fingolimod therapy","volume":"84","author":"Naoum","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2021.09.009_bib0060","doi-asserted-by":"crossref","first-page":"21832","DOI":"10.3390\/ijms160921832","article-title":"Adaptive immune responses in a multiple sclerosis patient with acute varicella-zoster virus reactivation during treatment with fingolimod","volume":"16","author":"Harrer","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2021.09.009_bib0065","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0b013e3182735d24","article-title":"Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod","volume":"79","author":"Gross","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2021.09.009_bib0070","doi-asserted-by":"crossref","first-page":"101963","DOI":"10.1016\/j.msard.2020.101963","article-title":"Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series","volume":"40","author":"Signoriello","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:43:56Z","timestamp":1758519836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721007670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0035378721007670"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2021.09.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Varicella-Zoster Virus meningitis in a multiple sclerosis patient treated with fingolimod","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}